Refine
Document Type
- Article (8)
Language
- English (8)
Has Fulltext
- yes (8)
Is part of the Bibliography
- no (8)
Keywords
- liver transplantation (3)
- multidrug resistance (2)
- Antibiotic steward-ship (1)
- Antibiotics (1)
- Biliary physiology (1)
- ESBL (1)
- Hepatocellular carcinoma (1)
- Infection (1)
- Infectious disease (1)
- Liver cancer (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Multidrug resistance (1)
- Multidrug-resistant organisms (1)
- Primary sclerosing cholangitis (1)
- Salmonella choleraesuis (1)
- Survival (1)
- VRE (1)
- antibiotic therapy (1)
- antimicrobial stewardship (1)
- ascites (1)
- biliary stricture (1)
- carbapenem resistance (1)
- cirrhosis (1)
- death rates (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- epidemiology (1)
- infection control (1)
- liver cirrhosis (1)
- medical risk factors (1)
- pseudomonas aeruginosa (1)
- recurrent cholangitis (1)
- screening routine (1)
- short-course antibiotic therapy (1)
- transmission (1)
- whole-genome sequencing (1)
Institute
Molecular surveillance of carbapenem-resistant gram-negative bacteria in liver transplant candidates
(2021)
Background: Carbapenem-resistant Gram-negative bacteria (CRGN) cause life-threatening infections due to limited antimicrobial treatment options. The occurrence of CRGN is often linked to hospitalization and antimicrobial treatment but remains incompletely understood. CRGN are common in patients with severe illness (e.g., liver transplantation patients). Using whole-genome sequencing (WGS), we aimed to elucidate the evolution of CRGN in this vulnerable cohort and to reconstruct potential transmission routes.
Methods: From 351 patients evaluated for liver transplantation, 18 CRGN isolates (from 17 patients) were analyzed. Using WGS and bioinformatic analysis, genotypes and phylogenetic relationships were explored. Potential epidemiological links were assessed by analysis of patient charts.
Results: Carbapenem-resistant (CR) Klebsiella pneumoniae (n=9) and CR Pseudomonas aeruginosa (n=7) were the predominating pathogens. In silico analysis revealed that 14/18 CRGN did not harbor carbapenemase-coding genes, whereas in 4/18 CRGN, carbapenemases (VIM-1, VIM-2, OXA-232, and OXA-72) were detected. Among all isolates, there was no evidence of plasmid transfer-mediated carbapenem resistance. A close phylogenetic relatedness was found for three K. pneumoniae isolates. Although no epidemiological context was comprehensible for the CRGN isolates, evidence was found that the isolates resulted of a transmission of a carbapenem-susceptible ancestor before individual radiation into CRGN.
Conclusion: The integrative epidemiological study reveals a high diversity of CRGN in liver cirrhosis patients. Mutation of carbapenem-susceptible ancestors appears to be the dominant way of CR acquisition rather than in-hospital transmission of CRGN or carbapenemase-encoding genetic elements. This study underlines the need to avoid transmission of carbapenem-susceptible ancestors in vulnerable patient cohorts.
Objectives: Rising prevalence of multidrug-resistant organisms (MDRO) is a major health problem in patients with liver cirrhosis. The impact of MDRO colonization in liver transplantation (LT) candidates and recipients on mortality has not been determined in detail.
Methods: Patients consecutively evaluated and listed for LT in a tertiary German liver transplant center from 2008 to 2018 underwent screening for MDRO colonization including methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant gram-negative bacteria (MDRGN), and vancomycin-resistant enterococci (VRE). MDRO colonization and infection status were obtained at LT evaluation, planned and unplanned hospitalization, three months upon graft allocation, or at last follow-up on the waiting list.
Results: In total, 351 patients were listed for LT, of whom 164 (47%) underwent LT after a median of 249 (range 0–1662) days. Incidence of MDRO colonization increased during waiting time for LT, and MRDO colonization was associated with increased mortality on the waiting list (HR = 2.57, p<0.0001. One patients was colonized with a carbapenem-resistant strain at listing, 9 patients acquired carbapenem-resistant gram-negative bacteria (CRGN) on the waiting list, and 4 more after LT. In total, 10 of these 14 patients died.
Conclusions: Colonization with MDRO is associated with increased mortality on the waiting list, but not in short-term follow-up after LT. Moreover, colonization with CRGN seems associated with high mortality in liver transplant candidates and recipients.
Background and aims: Spontaneous bacterial peritonitis (SBP) is a severe complication of decompensated cirrhosis. The prevalence of multidrug-resistant organisms (MDROs) in patients with cirrhosis is increasing. Identification of patients at risk for SBP due to MDROs (ie, SBP with the evidence of MDROs or Stenotrophomonas maltophilia in ascitic culture, MDRO-SBP) is crucial to the early adaptation of antibiotic treatment in such patients. We therefore investigated whether MDROs found in ascitic cultures can also be found in specimens determined by noninvasive screening procedures.
Patients and methods: This retrospective study was conducted at the liver center of the University Hospital Frankfurt, Germany. Between 2011 and 2016, patients with cirrhosis were included upon diagnosis of SBP and sample collection of aerobic/anaerobic ascitic cultures. Furthermore, the performance of at least one complete MDRO screening was mandatory for study inclusion.
Results: Of 133 patients diagnosed with SBP, 75 (56.4%) had culture-positive SBP and 22 (16.5%) had MDRO-SBP. Multidrug-resistant Escherichia coli (10/22; 45.5%) and vancomycin-resistant enterococci (7/22; 36.4%) resembled the major causatives of MDRO-SBP. Rectal swabs identified MDROs in 17 of 22 patients (77.3%) who developed MDRO-SBP with a time-dependent sensitivity of 77% and 87% after 30 and 90 days upon testing, while negative predictive value was 83% and 76%, respectively. The majority of patients were included from intensive care unit or intermediate care unit.
Conclusion: MDRO screening may serve as a noninvasive diagnostic tool to identify patients at risk for MDRO-SBP. Patients with decompensated cirrhosis should be screened for MDROs from the first day of inpatient treatment onward.
Massive global spread of multidrug-resistant (MDR) Salmonella spp. expressing extended-spectrum beta-lactamase (ESBL) and additional resistance to fluoroquinolones has often been attributed to high international mobility as well as excessive use of oral antibiotics in livestock farming. However, MDR Salmonella spp. have not been mentioned as a widespread pathogen in clinical settings so far. We demonstrate the case of a 25-year-old male with primary sclerosing cholangitis who tested positive for MDR Salmonella enterica serotype Choleraesuis expressing ESBL and fluoroquinolone resistance. The pathogen was supposedly acquired during a trip to Thailand, causing severe fever, cholangitis and pancreatitis. To our knowledge, this is the first report of Salmonella enterica serotype Choleraesuis in Europe expressing such a multidrug resistance pattern. ESBL resistance of Salmonella enterica spp. should be considered in patients with obstructive biliary tract pathology and travel history in endemic countries.
Introduction: MDRO-colonization has been shown to impair survival in patients with hematological malignancies and solid tumors as well as in patients with liver disease. Despite the increasing spread of multidrug-resistant organisms (MDRO), its impact on patients with hepatocellular carcinoma (HCC) has not been studied. We conducted this retrospective study to analyze the impact of MDRO-colonization on overall prognosis in HCC patients.
Materials and methods: All patients with confirmed HCC diagnosed between January 2008 and December 2017 at the University Hospital Frankfurt were included in this study. HCC patients with a positive MDRO screening before or within the first 90 days after diagnosis of HCC were defined as colonized HCC patients, HCC patients with a negative MDRO screening were defined as noncolonized HCC patients.
Results: 59 (6%) colonized and 895 (94%) noncolonized HCC patients were included. Enterobacterales with extended-spectrum β-lactamase-like phenotype with or without resistance to fluoroquinolones (ESBL/ ± FQ) were the most frequently found MDRO with 59%, followed by vancomycin-resistant Enterococcus faecium with 37%. Colonized HCC patients had more severe cirrhosis and more advanced HCC stage compared to noncolonized HCC patients. Colonized HCC patients showed an impaired survival with a median OS of 189 days (6.3 months) compared to a median OS of 1001 days (33.4 months) in noncolonized HCC patients. MDRO-colonization was identified as an independent risk factor associated with survival in multivariate analysis.
Conclusion: MDRO-colonization is an independent risk factor for survival in patients with HCC highlighting the importance of regular MDRO screening, isolation measures as well as interdisciplinary antibiotic steward-ship programs to guide responsible use of antibiotic agents.
Objectives: Stenosis of the biliary anastomosis predisposes liver graft recipients to bacterial cholangitis. Antibiotic therapy (AT) is performed according to individual clinical judgment, but duration of AT remains unclear.
Methods: All liver graft recipients with acute cholangitis according to the Tokyo criteria grade 1 and 2 after endoscopic retrograde cholangiography (ERC) were included. Outcome of patients treated with short AT (<7 days) was compared to long AT (>6 days). Recurrent cholangitis (RC) within 28 days was the primary end point.
Results: In total, 30 patients were included with a median of 313 (range 34–9849) days after liver transplantation until first proven cholangitis. Among 62 cases in total, 51/62 (82%) were graded as Tokyo-1 and 11/62 (18%) as Tokyo-2. Overall median duration of AT was 6 days (1–14) with 36 cases (58%) receiving short AT and 26 (42%) receiving long AT. RC was observed in 10 (16%) cases, without significant difference in occurrence of RC in short versus long AT cases. CRP and bilirubin were significantly higher in patients with long AT, while low serum albumin and low platelets were associated with risk of RC.
Conclusion: A shorter antibiotic course than 7 days shows good results in selected, ERC-treated patients for post-transplantation biliary strictures.
Reconstructing Oligocene-Miocene paleoelevation contributes to our understanding of the evolutionary history of the European Alps and sheds light on geodynamic and Earth’s surface processes involved in the development of Alpine topography. Despite being one of the most intensively explored mountain ranges worldwide, constraints on the elevation history of the European Alps, however, remain scarce. Here we present stable and clumped isotope geochemistry 15 measurements to provide a new paleoelevation estimate for the mid-Miocene (~14.5 Ma) European Central Alps. We apply stable isotope δ-δ paleoaltimetry on near sea level pedogenic carbonate oxygen isotope (δ18O) records from the Northern Alpine Foreland Basin (Swiss Molasse Basin) and high-Alpine phyllosilicate hydrogen isotope (δD) records from the Simplon Fault Zone (Swiss Alps). We further explore Miocene paleoclimate and paleoenvironmental conditions in the Swiss Molasse Basin through carbonate stable (δ18O, δ13C) and clumped (Δ47) isotope data from three foreland basin sections in different 20 alluvial megafan settings (proximal, mid-fan, and distal). Combined pedogenic carbonate δ18O values and Δ47 temperatures (30 ± 5°C) yield a near sea level precipitation δ18Ow value of -5.8 ± 0.2‰ and in conjunction with the high-Alpine phyllosilicate δD record suggest that the region surrounding the SFZ attained surface elevations of >4000 m no later than the mid-Miocene. Our near sea level δ18Ow estimate is supported by paleoclimate (iGCM Echam5-wiso) modeled δ18O values, which vary between -4.2 and -7.6‰ for the Northern Alpine Foreland Basin.
Reconstructing Oligocene–Miocene paleoelevation contributes to our understanding of the evolutionary history of the European Alps and sheds light on geodynamic and Earth surface processes involved in the development of Alpine topography. Despite being one of the most intensively explored mountain ranges worldwide, constraints on the elevation history of the European Alps remain scarce. Here we present stable and clumped isotope measurements to provide a new paleoelevation estimate for the mid-Miocene (∼14.5 Ma) European Central Alps. We apply stable isotope δ–δ paleoaltimetry to near-sea-level pedogenic carbonate oxygen isotope (δ18O) records from the Northern Alpine Foreland Basin (Swiss Molasse Basin) and high-Alpine phyllosilicate hydrogen isotope (δD) records from the Simplon Fault Zone (Swiss Alps). We further explore Miocene paleoclimate and paleoenvironmental conditions in the Swiss Molasse Basin through carbonate stable (δ18O, δ13C) and clumped (Δ47) isotope data from three foreland basin sections in different alluvial megafan settings (proximal, mid-fan, and distal). Combined pedogenic carbonate δ18O values and Δ47 temperatures (30±5 ∘C) yield a near-sea-level precipitation δ18Ow value of ‰ and, in conjunction with the high-Alpine phyllosilicate δD value of ‰, suggest that the region surrounding the Simplon Fault Zone attained surface elevations of >4000 m no later than the mid-Miocene. Our near-sea-level δ18Ow estimate is supported by paleoclimate (iGCM ECHAM5-wiso) modeled δ18O values, which vary between −4.2 ‰ and −7.6 ‰ for the Northern Alpine Foreland Basin.